Lamivudine
- Product NDC
- 68180-602
- 11-digit product format
- 681800602
- Labeler code
- 68180
- Product ID
- 68180-602_0852eda3-c1d3-426d-b73d-c7f08dfd9584
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA205217
- Marketing category
- ANDA
- Marketing start
- 2015-03-25
- Substance
- LAMIVUDINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lamivudine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LAMIVUDINE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2T8Q726O95 |
| Rxcui | 199147, 349491 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-602-01 | Lamivudine | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 15 |
| 68180-602-07 | Lamivudine | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 7 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-602 | LAMIVUDINE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20240104_ff3b5265-f533-4332-a861-d8c9c1664ffd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-602-01 | 68180060201 | 100 TABLET, FILM COATED in 1 BOTTLE (68180-602-01) | 2015-03-25 | 0000-00-00 | No | No | Current |
| 68180-602-07 | 68180060207 | 60 TABLET, FILM COATED in 1 BOTTLE (68180-602-07) | 2015-03-25 | 0000-00-00 | No | No | Current |